JB Chemicals & Pharmaceuticals Ltd. ( (IN:JBCHEPHARM) ) has issued an update.
JB Chemicals & Pharmaceuticals Ltd. has received approval from the US FDA for its Abbreviated New Drug Application (ANDA) for Bisoprolol Tablets USP, a generic version of Zebeta, used in managing hypertension. This approval marks a significant step for the company in expanding its portfolio in the US market, potentially enhancing its competitive position and offering more affordable treatment options for hypertension patients.
More about JB Chemicals & Pharmaceuticals Ltd.
JB Chemicals & Pharmaceuticals Ltd. operates in the pharmaceutical industry, focusing on the development and production of generic drugs. The company is known for its range of pharmaceutical products aimed at addressing various health conditions, with a particular emphasis on the cardiovascular segment.
YTD Price Performance: -11.95%
Average Trading Volume: 6,998
Current Market Cap: 253.3B INR
For an in-depth examination of JBCHEPHARM stock, go to TipRanks’ Stock Analysis page.